Trials / Completed
CompletedNCT01457768
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects With Chronic Hepatitis C Infection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 570 (actual)
- Sponsor
- Gilead Sciences · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This Registry is designed to obtain long term data on participants who have failed to achieve sustained virologic response (SVR) while receiving at least one Gilead oral antiviral agent (OAV) in a previous Gilead-sponsored hepatitis C virus (HCV) study.
Conditions
Timeline
- Start date
- 2011-12-19
- Primary completion
- 2018-04-09
- Completion
- 2018-04-09
- First posted
- 2011-10-24
- Last updated
- 2018-05-04
Locations
323 sites across 16 countries: United States, Australia, Austria, Canada, Czechia, Estonia, France, Germany, Italy, Netherlands, New Zealand, Poland, Puerto Rico, Spain, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT01457768. Inclusion in this directory is not an endorsement.